CANNABIS THERAPEUTIC RESEARCH
PROGRAM
REPORT to the CALIFORNIA
LEGISLATURE
Prepared by the
RESEARCH ADVISORY PANEL
350 McAllister Street, Room 6000
San Francisco, California 94102
TABLE OF CONTENTS
- Panel Members and Staff
- Executive Summary
- Cancer Chemotherapy, Nausea and Vomiting
- The-Problem
- Inadequacy of Drugs in Current Use
- Early Experience with Marijuana and THC
- Cannabis Therapeutic Program
- Legislative History
- The Research Advisory Panel
- Panel's Role in Development of Legislation
- Summary of Legislation
- Extension of Law and Provision for Glaucoma Studies
- Implementation of the New Law
- Protocol Development
- Drug Supply
- Cost
- Investigator Eligibility
- Physician Enrollment
- Research Subjects
- Research Subject Protection
- Study Objectives
- Protocol History
- Data Collection
- Data Quality Control
- Abuse
- Site Visits
- Dissemination of Findings and Results
- Detailed Protocol Results
- Number of Patients Treated
- Initial Trial
- Cumulative Dose Study
- Combination Protocol
- Results of Study with Smoked Marijuana
- Protocol Exceptions (Pilot Protocols)
- Results of the Controlled Study Protocols
- Glaucoma Protocol
- Post Marketing Survey of Investigators
- Discussion of Results of Cannabis Therapeutic Program
- Approval by FDA for Marketing of THC and Conclusion of the Cannabis Therapeutic Program
- Approval and Rescheduling
- Investigational THC no Longer Supplied by NCI
- Credits
Contents | Feedback
| Search | DRCNet Home Page | Join DRCNet
DRCNet Library | Schaffer Library | Hemp (Marijuana) | Medical Information
Drug Rehab